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Background: Type 2 diabetes mellitus requires an 
efficient management strategy aimed at preventing long-
term complications and decreasing mortality. Detection 
and proper care early on is especially important due to 
the 'legacy effect', i.e. further reduction of morbidity and 
mortality due to effective initial management. 
Objectives: To assess the level of diabetes care 
provided at Rabat Health Centre, comparing it with 
international standards to identify any shortcomings and 
implement changes required. 
Methods: An audit of diabetes management during 
2008 was carried out retrospectively on 60 randomly 
selected type 2 diabetics who attend the diabetes clinic 
at Rabat Health Centre. A reaudit was carried out the 
following year. 
Results: Reaudit showed a disappointing lack of 
improvement in glycaemic and lipid control despite 
implementation of changes. However, there was better 
control of hypertension and weight management, 
together with more prophylactic use of aspirin. 
Conclusion: Improved care was achieved in many 
areas but more must be done to ensure optimal 
management and outcome in all patients according to 
international guidelines. A protocol should be in place 
to ensure standardised care. 
Introduction 
Type 2 diabetes mellitus is an increasingly common, chronic 
condition characterized by decreased insulin output by the 
pancreatic beta cells, and petipheral insulin resistance. Genetic 
factors, in addition to the increasing incidence of obesity in 
developed countries secondary to poor dietary habits and 
lack of exertion, contribute to this epidemic. Complications 
of diabetes pose a high financial, social and personal burden, 
which can be decreased by primary prevention, early detection 
and optimal management according to set standards CTable 1). 
Lack of proper care in diabetes would result in a very 
high risk of micro and macrovascular complications. The 
importance of effective early management to prevent 
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Table l - Set Standards for Optimal Diabetes Care according to American Diabetes Association 
(ADA) Guidelines 
HbAlc 
Blood Pressure 
Total Cholesterol 
Prophylactic Aspirin 
At least twice yearly reviews I 
BMI 
Exercise 
Smoking status 
Yearly blood investigations, ophthalmic reviews 
and foot exams I 
*Recol1lll1cllda/iolls clw llged iil 2010 
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< 7%, repeated at least twice yearlyl 
< 130/80mmHgl.2 
<5.0mmoW 
>40yrs unless complications presentH3 
18.5-24.9Kglm1 I 
150mins moderate intensity, weeklyl 
Record status + cessation advice 
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later complications has been effectively demonstrated 
and is called the legacy effect4. Microvascular disease 
includes retinopathy, nephropathy and neuropathy, 
while macrovascular disease involves the coronary, 
cerebral and peripheral arteries. Efficient glycaemic and 
blood pressure control, management of dyslipidaemia, 
institution of lifestyle measures , prophylactic use of 
aspirin and smoking cessation advice all contribute to 
optimal diabetes care aimed at reducing morbidity and 
mortality. 
Primary care plays a large role in educating the public, 
early detection of diabetes and pre-diabetes through 
screening, while minimising the onset of complications 
through intervention5, thus reducing the burden on 
secondary care. 
This audit was performed to measure the level of care 
provided at Rabat Health Centre and institute changes 
in practice where required. 
Methods 
Sixty patients were randomly chosen from the computerized 
diabetic register at Rabat Health Centre, equivalent to 13% of 
a total of 459 type 2 diabetics. Type l diabetics are under 
secondary care. The patients' ages ranged between 47 and 84 
years. A specified dataset containing both process components 
e.g. frequency of blood pressure measurement, and outcome 
data measures e.g. cholesterollevels, was set up and this data 
was collected retrospectively from the patients' files over the 
period l st January to 31st December 2008. 
After identifying shoncomings and instituting changes 
in practice, data was again obtained retrospectively from the 
same cohon, the following year. There were no deaths in this 
sample during this time period but 4 patients were los t to either 
dropout or continued care at Mater Dei Hospital. 
Results 
The first audit showed that the basic structures for 
optimal diabetic care were in place, with regular review, and 
weighing and blood pressure monitoring at every visit. In 
fact, nearly 90% of patients were being reviewed twice or 
more yearly and had yearly blood investigations. However, 
it also revealed some areas where a change in practice was 
indicated, where less clinician inertia and more aggressive 
measures were needed in order to achieve optimal goals. 
For example, only 20% of patients had twice-yearly HbAlc 
measurement as recommended l, while 44% of patients 
not on antihypertensives had uncontrolled blood pressure 
(> 130/80mmHg). 
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Diagram l - Level of Glycaemic Control 
Comparison 2008 & 2009 
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Diagram 2 - Control of Blood Pressure 
Comparison 2008 & 2009 
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Diagram 3 - Control of Cholesterol Level 
Comparison 2008 & 2009 
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The following were the recommendations after the 
first audit: 
• HbAlc to be taken twice yearly in all patients and 
quarterly in uncontrolled patients (HbAlc > 7%). 
• a) Starting treatment with OHA's in diabetics with 
HbAlc > 7% who are not already on treatment. 
b) An increase in dose or number of OHA's when 
HbAlc > 7% in patients on treatment. 
c) Starting insulin when HbAlc > 7% and patient 
is on maximum doses of OHA's. 
02008 
. 2009 
Maltese Family Doctor It-Tabib tal-Familja 
• To initiate antihypertensive therapy or increase 
dose or number of drugs when blood pressure is 
persistently > 130/80mmHg. 
• 
• 
Encouraging lifestyle changes. 
Starting statins as early as possible in 
dyslipidaemia. 
Measuring BMI in all patients . 
Starting low dose aspirin where indicated. 
Recording smoking status and providing smoking 
cessation advice. 
• Yearly referral to a dietician. 
• Yearly referral for ophthalmic and podology review. 
• Recording complications of diabetes. 
The results obtained on reaudit, a year after these 
recommendations were made, are discussed below. 
Discussion 
Glycaemic control 
Good glycaemic control is central to the management 
of diabetes. When this is achieved, there is decreased 
incidence of microvascular and neuropathic 
complications, improving outcome1, 3, 5. 
In this audit, glycaemic control was defined by an 
HbAlc level of < 7% as proposed by the American 
Diabetes Association1 There is still much controversy 
over the optimal level of glycaemic control, HbAlc 
< 6.5% being preferred by International Diabetes 
Federation (lDF)6. The latter more stringent level poses 
a higher risk of hypoglycaemia in older patients, while 
the Accord study?, with increased cardiovascular deaths 
in the intensive therapy arrn, has further muddied the 
waters. 
On reaudit, glycaemic control during 2009 was only 
achieved in 33% of patients, a decrease of 7 % from the 
previous year (diagraml). This result was unexpected but 
compares with a similar level of 36% in the U .5. back in 
20008 More patients were on oral hypoglycaemic agents 
(OHA's), while 60% of patients were tested for HbAlc 
twice or more during 2009, as per recommendations, up 
from only 20% during 2008. Actually, 13% of patients 
were tested every 3 to 4 months , as recommended 
in poorly controlled diabetics1, compared to only 3% 
during 2008. 
The results obtained , with no improvement in 
glycaemic control during 2009 despite instituting 
changes in management, are rather disappointing. There 
could be different reasons for this including the fact that 
Maltese Family Doctor It-Tabib tal-Familja 
a protocol was not in place and that initiating treatment 
with insulin or increasing the dose was only carried out 
in 6.7% of patients during 2009. 
Blood pressure control 
Hypertension in diabetes doubles mortality and 
increases cardiovascular disease (CVD) by 75%9, besides 
leading to renal, cerebrovascular and retinal angiopathyl . 
There is a close association between good control of 
blood pressure in diabetes and a reduction in incidence 
of complications1, 10: the Steno-2 Study showed a decrease 
in CVD by 53% and of microvascular complications 
by 58-63%11 An emphasis should be made on regular 
monitoring and adequate control by both life-style 
measures and adequate drug therapy. Various studies 
have shown that multidrug regimens are more effective 
in controlling hypertension.1, 10 
All patients attending primary care diabetes clinics have 
their blood pressure measured at each visit. On reaudit, 53% 
of patienrs were adequately controlled « 130/80mmHg) as 
compared with 43% during 2008 (diagram 2). This compares 
favourably with a level of only 28% of conrrolled patienrs in 
a study carried out in Australia during 200813 Additionally, 
75% of patienrs reviewed were now on anrihypertensives (l 
to 4 different agents), up by 5% from 2008. This data shows 
a satisfactory improvemenr in blood pressure control coupled 
with increased use of drug therapy. 
Lipid control 
Dyslipidaemia is closely associated with diabetes 
mellitus. Hypercholesterolaemia, hypertriglyceridaemia, 
high lDl and low HDl are all contributory factors towards 
an increased risk of CVD. lipid levels were measured 
yearly in nearly all the patients in this audit. For the sake of 
simplicity only cholesterollevels are being considered here, 
the target being a level of < 5 mmol!ll . The ADA guidelines 
based on various studies recommend that all diabetics with 
CVD, and those over 40, with CVD risk factors but regardless 
of lipid levels, would benefit from taking statins1.14. 
Unfortunately, there was no improvement in lipid 
control on reaudit (diagram 3). The use of statins had 
not increased, remaining at 52%, while 45% of the total 
number of patients remained uncontrolled. On reaudit, 
60% of diabetics not on statins were uncontrolled, as 
compared to 45% in 2008, while 45% of patients on 
statins were also uncontrolled (34% in 2008). The latter 
result could be due to dietary excess or inadequate doses. 
These alarming statistics should be a cause for 
concem, considering the high risk of CVD in diabetic 
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patientsl+ Despite international recommendations for the 
use of statins as outlined above, we are as yet not doing 
enough in our clinics, largely due to local policies which 
do not concur with these recommendations. 
Life-style measures 
WeigJtt control 
Weight 1055 decreases insulin resistance l . This in 
turn decreases hyperglycaemia and the consequent risk 
of CVD 14. Body Mass Index (BMI) is a reliable way of 
measuring whether patients are of normal weight for their 
height l , preferably maintaining it at a level between 18.5 
and 24.99 kglm2 
As in 2008, all patients auending for diabetic review 
during 2009 had their weight recorded. Overall more 
patients lost weight than gained, 43% vs. 33%. In 17% 
of patients no change in weight was recorded. A similar 
trend had been seen during the initial audit. 
BMI was only calculated in 7% of patients during 
both years. (This has now become routine since jan 2010.) 
Five patients were referred to a dietician during 2009 as 
compared to only one during 2008. 
The persistent higher rate of weight 1055 rather than 
weight gain was encouraging. Continuous emphasis on 
the benefits of weight reduction together with referral 
for dietary advice is an important part of diabetes 
management. However, many patients declined referral 
to a dietician at Mater Dei Hospital, preferring to auempt 
dieting on their own. 
Exercise 
An exercise regimen of moderate intensity physical 
activity of 150 minutes weeldyl should be recommended 
to all patients as it decreases CVD risk factors and 
promotes weight 1055. Lack of data has precluded this 
factor from being included in this audit. 
Number of diabetic reviews 
Over 90% of patients were reviewed twice or more 
during 2009, slightly more than during 2008. This 
correlates well with international recommendations of at 
least twice yearlyvisits in controlled patients, less controlled 
patients being seen more often depending on response to 
treatment changes l . During 2009 there was an increase in 
frequencyof reviews, 58% having3 reviews (35% in 2008), 
23% being seen 4 times (5% in 2008) and nearly 7% having 
5 reviews (none in 2008). 
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As expected, the level of glycaemic control falls with 
the frequency of visits. The only patient with one review 
was well controlled, as were half the patients with 2 and 
3 reviews. On the other hand, almost all patients with 4 
or 5 reviews were uncontrolled. These findings were very 
similar to 2008 figures , but the increase in frequency of 
reviews during 2009 means that recommendations for 
more frequent reviews in uncontrolled patients were 
being followed. 
Use of aspirin 
Aspirin is a useful drug in the primary and secondary 
prevention of CVD in diabetes3 It is associated with a 30% 
decrease in myocardial infarctions and a 20% decrease in 
strokes l . At the time of audit, aspirin was recommended 
in all diabetics over 40 years of age or when another risk 
factor was presentI, unless contraindicated. The ADA 
has modified these recommendations this year to use 
of aspirin in males over 50 years, and over 60 years in 
females, unless another risk factor is presentl6. 
At reaudit, 73% of patients were on aspirin compared 
to 62% during 2008, indicating an improvement in 
adherence to guidelines. 
Smoking 
Smoking is associated with a much higher risk of 
CVD, microvascular disease and premature death in 
diabetes l ; therefore it is of utmost importance to record 
smoking status 50 that the opportunity can be taken 
to provide smoking cessation advice when necessary. 
This status was recorded in 73% of cases on reaudit, an 
improvement of 30%. (Smohing status routine~ recorded 
sinee jan 2010). 
Preventive measures 
Although yearly ophthalmic reviews are 
recommended l , this was only carried out on just over 
half the patients on both audit and reaudit, probably 
due to excessively long waiting lists. Fundoscopy can 
be performed during routine diabetic review if time 
allows , but should not replace examination by an 
ophthalmologist/optometristI6 . 
Yearly blood investigations were carried out in 95% 
of patients. 
Only 3% of patients had a foot examination during 
reaudit, a further decrease of 7% from 2008, perhaps due to 
time constraints. (Routineyear~ podologist review si nee jan 2010). 
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Conclusion 
Reaudit showed improvement in diabetic care on 
many levels but much remains to be done in particular 
areas. Unfortunately, the increase in frequency of reviews, 
HbAlc testing and increased use of OHA's were not 
effective in improving overall glycaemic control. Besides 
lack of an official protocol, clinician inertia in starting 
insu!in Conly 6.7% during 2009) may have played a part. 
The management of hypertension in the selected 
diabetic patients was more successful. An increase in the 
appropriate use of antihypertensives has been translated 
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